Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | MGAM | O43451 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | SI | P14410 | 2/20 | 0.43 |
| ▸ | MGAM2 | Q2M2H8 | 2/20 | 0.43 |
| ▸ | MMP1 | P03956 | 4/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 3/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7631058 | 0.87 | TSHR (0.44) | TSHRHSD17B10MGAMGAASI | |
| SCHEMBL10329464 | 0.84 | TSHR (0.41) | TSHRHSD17B10MGAMGAASI | |
| SCHEMBL7784843 | 0.83 | TSHR (0.50) | TSHRHSD17B10MGAMGAASI | |
| SCHEMBL11809153 | 0.82 | ACE (0.43) | TSHRHSD17B10MGAMGAASI | |
| SCHEMBL8499849 | 0.81 | — | — | |
| SCHEMBL690378 | 0.81 | — | — | |
| SCHEMBL5898830 | 0.81 | — | — | |
| SCHEMBL9876817 | 0.79 | TSHR (0.46) | TSHRHSD17B10MGAMGAASI | |
| SCHEMBL5898819 | 0.77 | — | — | |
| SCHEMBL8576325 | 0.77 | TSHR (0.44) | TSHRHSD17B10MGAMGAASI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9829487-B2 | Self-assembled monolayers and methods for using the same in biosensing applications | NUTECH VENTURES (US) | 2017-11-28 | — | — | US | disclosed |
| US-9079835-B2 | Self-assembled monolayers and methods for using the same in biosensing applications | NUTECH VENTURES (US) | 2015-07-14 | — | — | US | disclosed |
| US-20120315625-A1 | SELF-ASSEMBLED MONOLAYERS AND METHODS FOR USING THE SAME IN BIOSENSING APPLICATIONS | NATIONAL SCIENCE FOUNDATION | 2012-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120315625-A1 | SELF-ASSEMBLED MONOLAYERS AND METHODS FOR USING THE SAME IN BIOSENSING APPLICATIONS | SPR, SAMSN1, NAPA | TSHR 3540/4885HSD17B10 2136/4885MGAM 2022/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.